Miller · Advances in health economics and health services research 2008 · retrospective economic expenditure analysis · n=?

Quantifying national spending on wellness and prevention.

Cited 29 times in the scientific literature.

Level 4 - case-series / case-control

Economic expenditure analysis using aggregate national accounts, graded by design analogy

PubMed 19548511 · record verified 2026-08-29

What was done

The authors estimated US national expenditures on primary and secondary prevention from 1996 to 2004 across eight categories. They supplemented the National Health Expenditure Accounts (NHEA) with auxiliary datasets, subdividing expenditures into components (including primary prevention, secondary screening, research, and public health activities) to assess sensitivity across different definitions of prevention.

What was found

Total prevention spending increased in current dollars from $83.2 billion in 1996 to $159.8 billion in 2004. As a share of total NHEA, prevention spending rose from 7.8% in 1996 to 8.6% in 2004, peaking at 9.0% in 2002 before declining due to reduced public health spending shares. Primary prevention comprised roughly half of all prevention spending. In 2004, depending on the scope applied, estimated prevention spending represented: 8.6% (full definition), 8.1% (excluding research), 5.1% (primary prevention plus screening), 4.2% (primary prevention alone), or 2.8% (public health expenditures alone).

Why it matters

Commonly cited claims that prevention accounts for only ~3% of US healthcare spending reflect narrow definitions focused almost exclusively on public health budgets; broader accounting inclusive of clinical prevention and screening places the figure closer to 5% to 9%.

Limits

The analysis relies on secondary accounting allocations rather than directly audited expenditures. Estimates reflect current-dollar figures without inflation adjustments in the abstract and are highly sensitive to definitional choices. Data are limited to the 1996–2004 period and do not capture health outcomes, cost-effectiveness, or wellness investments outside standard health accounts.

Cited by